Abstract
The following is a case of multidrug-resistant pulmonary tuberculosis (MDR-TB) that was treated successfully with a linezolid-containing regimen. It was found that linezolid is an efficient medicine for MDR-TB treatment with an acceptable side effect profile. Treatment was maintained for 18. months, and closely monitoring toxicities did not reveal evidence of any neurologic adverse effects. However, despite our expectation, thrombocytopenia was seen after 2. years follow-up.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 233-236 |
| Number of pages | 4 |
| Journal | International Journal of Mycobacteriology |
| Volume | 2 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2013 |
Keywords
- Linezolid
- Multidrug-resistant tuberculosis
- Thrombocytopenia
- Treatment
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Fingerprint Dive into the research topics of 'Multidrug-resistant tuberculosis treatment with linezolid-containing regimen'. Together they form a unique fingerprint.
Cite this
Farshidpour, M., Ebrahimi, G., & Mirsaeidi, M. (2013). Multidrug-resistant tuberculosis treatment with linezolid-containing regimen. International Journal of Mycobacteriology, 2(4), 233-236. https://doi.org/10.1016/j.ijmyco.2013.09.002